Gefapixant for Chronic Cough

Conclusions are also beholden to methodological design, often discordant from those of subsequent randomized clinical trials. Such may be the case with the recently published dose-response meta-analysis of studies examining efficacy and tolerability of gefapixant for refractory or unexplained chronic cough.
Source: JAMA - Category: General Medicine Source Type: research